Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2026 Mar 26;16:1743124. doi: 10.3389/fonc.2026.1743124

Hospital-to-hospice transfers in Germany: analyzing the impact of age and gender at the care transition interface

Christiane von Sass 1,*, Birgitt van Oorschot 2, Tabea Sammer 1,3, Martina Kern 4, Lukas Radbruch 5, Marc Rütters 1, Nazife Dinc 6, Marcel A Kamp 1,7
PMCID: PMC13061869  PMID: 41971449

Abstract

Background

Hospice care models vary worldwide due to differences in healthcare systems, cultural attitudes, and resource availability. In Germany, inpatient hospice care plays a vital role in the treatment of critically ill patients, providing inpatient end-of-life care if home care is not possible. The transition between different care settings is a critical interface. This study analyzes aggregated 2023 hospital data to assess the frequency and characteristics of direct transfers from hospitals to inpatient hospices and evaluates the impact of regional infrastructure on these transitions.

Methods

We conducted a cross-sectional analysis of aggregated data from all German hospital stays in 2023, using nationwide hospital billing data reported under §21 of the Hospital Remuneration Act. The study included adult cases and employed linear regression to examine the association between regional bed density and transfer rates.

Results

In 2023, 15,656 cases resulted in a transfer to an inpatient hospice. This transfer rate varied by region, with the highest rates in Saarland and Brandenburg (0.2% and 0.19%, respectively) and the lowest in Bavaria (0.05%). Hospital to hospice transfers accounted for 32.7% of all hospice admissions. Over 75% of hospice transfers were aged 65 or older. Female patients comprised 53.6% of the hospice transfer cohort, reflecting a significant disparity likely linked to limited informal spousal support. Oncological diseases were the primary diagnosis in 68.8% of cases. Transfer rates correlated strongly with regional hospice bed density (R2 = 0.65) but showed no association with outpatient palliative care density or socioeconomic indicators.

Conclusions

Hospital-to-hospice transfers in Germany follow a supply-driven logic where regional capacity outweighs clinical demand. These transitions primarily involve elderly patients and women vulnerable to the collapse of informal support networks. As healthcare policy seeks to integrate inpatient and outpatient sectors, these findings serve as a benchmark for transitioning toward a needs-oriented planning model to ensure equitable end-of-life access.

Keywords: end of life disparities, hospital to hospice interface, inpatient hospice care, palliative care, regional bed density, supply driven care

Introduction

Hospice care varies worldwide due to differences in healthcare systems, cultural attitudes, and resource availability. In the United States, hospice care often relies on Medicare funding and includes multi-professional care (1, 2), while Canada provides public funding with varying coverage (3–6). The United Kingdom maintains a long-established, charity-based hospice movement funded by the National Health Service as well as by charitable donations (5, 7). However, hospice care in many developing countries struggles with limited resources and infrastructural challenges (5).

Germany’s palliative care system integrates general and specialized services, ensuring timely and continuous care for patients with complex symptoms (8, 9). In contrast to specialized outpatient palliative care, hospice care excludes further life-prolonging therapies, such as anti-tumor therapy. Inpatient hospices support individuals with advanced illnesses who can no longer be cared for at home. According to the updated framework agreement, admission to an inpatient hospice requires a medical certificate confirming a terminal illness that is progressing toward death within weeks or months, for which curative treatment is no longer possible. Additionally, it must be established that necessary palliative-medical and nursing care cannot be sufficiently or feasibly provided within the patient’s domestic or familiar environment (10, 11). Specialized palliative nurses deliver comprehensive care, while medical assistance is provided by general practitioners or specialized outpatient palliative care (SAPV) teams. The 2015 Hospice and Palliative Care Act (HPG) strengthened financial support and service coordination, increasing reimbursement rates and expanding outpatient funding (9). While insurance covers most inpatient hospice costs, charitable donations contribute to the remaining expenses. Outpatient hospice care, primarily supported by trained volunteers, provides psychosocial assistance, easing the burden on professional caregivers.

The transition between standard medical care and palliative or hospice care is a critical phase in the healthcare continuum. A qualitative study conducted in the United States examined the interface between hospital treatment and hospice care, identifying potential challenges in this transition (12). A 2016 mixed-methods retrospective analysis conducted in Augsburg and Bonn specifically identified pain-related complications occurring at healthcare interface points (13). While several high-quality studies, including those from German-speaking countries, have analyzed transitions between health care settings in the last year of life, no quantitative research has yet investigated hospital-to-hospice transfers (14, 15). This study aims to analyze the number of hospital cases transferred to hospice care and to further characterize this cohort.

Methods

Ethical approval and data accessibility

The study complied with the ethical standards set in the 1964 Declaration of Helsinki and its subsequent revisions. Approval for the study protocol was granted by the institutional and local ethics committee at Friedrich Schiller University Jena (Study ID: 2025-3696-BO-D) and Brandenburg Medical School, Germany (Study ID: 190032024-ANF). The findings align with the STROBE guidelines for observational studies [16].

Study design, setting, and data sources

This cross-sectional study utilized aggregated data from all hospitalizations across Germany in 2023. Data were based on the §21 of the Hospital Remuneration Act and sourced from the Institute for the Remuneration System in the Hospital Sector (InEK GmbH, Siegburg, Germany). Data on total hospice admissions were retrieved from the Federal Health Reporting Service (Gesundheitsberichterstattung des Bundes, https://www.gbe-bund.de/). Information regarding regional hospice bed density (beds per one million inhabitants) and the density of specialized outpatient palliative care (SAPV) teams (teams per one million inhabitants) was sourced from the pallCompare Monitor (https://www.bifg.de/projekte/pallcompare). As 2023 figures were unavailable for these specific metrics, data from 2024 were utilized for the analysis. Furthermore, the proportion of deceased individuals who received SAPV care during their final year of life was also extracted from the pallCompare Monitor. For this metric, 2022 was utilized as the most recent year of available data. Finally, the at-risk-of-poverty rate and the Gini index for 2023 were retrieved from the Federal Statistical Office of Germany (Statistisches Bundesamt) via the official sustainability reporting portal (https://www.statistikportal.de/de/nachhaltigkeit).

Cohort definition, participants, and study size

We defined the following inclusion criteria (1): classified as inpatient cases, (2) treated in 2023, and (3) involving patients aged 18 years or older. The study size reflects the total number of hospital stays meeting these criteria in 2023. We identified adult patients who were transferred from hospital to an inpatient hospice and compared this group with the overall cohort of inpatient cases in 2023. Due to technical constraints, the analysis focused on hospital cases without access to individual patient-level data.

Definitions and variables

As part of the German DRG system, discharge reasons must be coded and reported to INEK. Discharge to an inpatient hospice is classified under code 11, “Discharge to a hospice,” in accordance with Appendix 2 to Section 301 of the German Social Code Book V. Diagnoses were categorized using the International Statistical Classification of Diseases and Related Health Problems, 10th Revision, German Modification (ICD-10-GM). The DRG system assigns a single primary diagnosis per case while allowing multiple secondary diagnoses. Medical procedures and treatments were identified using the corresponding Operations and Procedures Codes (OPS) (16, 17).

The analysis examined the following variables:

  • - Total number of hospitalizations in 2023

  • - Reasons for hospital discharge or transfer, as documented in Section 301 of the German Social Code Book V

  • - Total number of hospital cases within each cohort

  • - Distribution of sex and age

  • - Primary and secondary diagnoses

  • - Hospital distribution based on bed capacity and ownership type

As the German Index of Socioeconomic Deprivation (GISD) is not available at the federal state level, alternative indicators were utilized to assess regional socioeconomic conditions. We employed the at-risk-of-poverty rate (defined as the percentage of the population falling below the state-specific median income) and the Gini index as a standardized measure of regional income and wealth inequality.

Addressing bias

Selection bias was minimized by including all DRG-based hospital-to-hospice transfers in Germany for 2023. Patients outside the DRG system, such as foreign self-paying patients, cannot be accounted for. Additionally, due to data protection regulations, cases with an annual frequency of fewer than five were not available. However, given the large dataset of over 15,000 cases analyzed per year, this limitation is unlikely to significantly affect the findings. As our analysis is based on insurance claims data, hospital case counts do not correspond directly to individual patients, as a single patient may experience multiple hospitalizations within a given year, particularly when receiving home care. However, because hospital cases may include multiple admissions per patient, whereas hospice transfers typically occur only once per individual, the observed proportion of hospital-to-hospice transfers remains a valid representation at the case level. To mitigate measurement bias, relevant cases were identified based on designated codes, associated diagnoses, and treatments using standardized ICD-10 coding. Although billing data may introduce minor classification errors, the consistent application of coding standards reduces this risk. Nonetheless, coding omissions remain a potential issue, particularly for non-revenue-relevant DRG codes recorded as secondary diagnoses and treatments. However, this does not apply to primary diagnoses or revenue-critical codes related to surgical procedures.

Data management and statistical analysis

Data were extracted from the InEK data browser and organized using Microsoft Excel for Mac (Version 16.93, Microsoft Corporation, Redmond, WA, USA). GraphPad Prism 9 for macOS (Version 9.5.1, GraphPad Software, La Jolla, CA, USA) was used for statistical analysis and visualization.

Descriptive statistics were used to calculate frequencies and ratios. The total number of cases for a given diagnosis included hospitalizations where the diagnosis appeared as either primary or secondary. To quantify disparities, we calculated Odds Ratios (OR) for age and gender and Risk Ratios (RR) for regional variations, including 95% confidence intervals (CI). Regional RR were calculated using the state with the lowest transfer rate (Bavaria) as the reference. CIs were estimated via log-transformation of the ratios, following standard epidemiological procedures (18). Linear regression analysis was performed to assess the association between regional hospice transfer rates (dependent variable) and inpatient hospice bed capacity per one million inhabitants (independent variable).

Results

German hospital cases

In 2023, German hospitals managed a total of 17,063,249 inpatient cases of which 15,200,893 inpatient cases were adult patients aged ≥18 years. Female patients accounted for 52.5% of these cases (7,977,960), male patients for 47.5% (7,222,035) and diverse patients or patients with unknown gender comprised 898 cases. Patients aged 65 years or older constituted 54.2% of all hospital cases (8,241,611, Table 1).

Table 1.

Epidemiology.

Total number of all hospital cases including patients ≥ 18 years Fatal hospital cases including patients ≥ 18 years
number of cases % number of cases %
All cases 15,200,893 439,315
Gender
Female 7,977,960 52.5% 202,203 46.0%
Male 7,222,035 47.5% 236,915 53.9%
Diverse 293 0% 1 0%
Unknown 605 0% 196 0%
Age groups
18-29 years 1,031,366 6.8% 1,150 0.3%
30-39 years 1,334,304 8.8% 2,893 0.7%
40-49 years 1,117,669 7.4% 7,086 1.6%
50-54 years 820,652 5.4% 8,533 1.9%
55-59 years 1,209,646 8.0% 16,602 3.8%
60-64 years 1,445,645 9.5% 26,737 6.1%
65-74 years 3,089,257 20.3% 85,890 19.6%
75-79 years 1,458,679 9.6% 54,291 12.4%
80+ years 3,693,675 24.3% 236,133 53.8%
≥65 years 8,241,611 54.2% 376.314 85.7%

Table 1 depicts an overview of case numbers, as well as age and sex distribution, among all hospitalized cases and and fatal cases in Germany in 2023.

Hospital discharges and cohort transferred to hospice

Among all hospital cases involving adult patients, the vast majority (13,148,998 cases, 86.5%, see Figure 1) resulted in patients being discharged home. A smaller proportion of patients were transferred to other facilities: 3.4% (516,443 cases) were transferred to another hospital, 1.8% (273,722 cases) to a rehabilitation facility, and 2.8% (430,701 cases) to nursing homes. Other discharge reasons accounted for 2.5% (376,058 cases). 2.9% (439,315 cases) of patients died during hospitalization. Among these, 46% were female (202,203 cases) and 54% were male (236,915 cases, with 197 cases classified as unknown or diverse). The odds of mortality were significantly lower for female patients compared to males (OR 0.77; 95% CI 0.76–0.77; Chi-square = 7093, df = 1, p <.0001; Figure 2).

Figure 1.

Sankey diagram illustrates outcomes of 17,063,249 German hospital cases, splitting into adults and children and showing discharge destinations including home, other hospitals, rehabilitation facilities, nursing homes, hospice care, death, and other reasons.

Sankey diagram illustrating discharges from German hospitals.

Figure 2.

Panel A contains a horizontal bar chart showing percentages of hospital cases, fatal cases, and hospital-to-hospice transfers by age group, highlighting highest fatality and transfers in patients aged eighty years or older. Panel B presents a horizontal bar chart comparing these metrics by sex, showing females represent a slight majority of cases and transfers, while males represent the majority of fatal cases.

Age groups and gender distribution. Figure 2 shows the relative age (A) and gender distribution (B) of all German hospital cases, fatal cases and those cases, in which patients were discharged to hospice care.

In a total of 15,656 hospital cases (0,12% of all German hospital cases), patients were transferred to inpatient hospices. However, the rate of hospice transfers varied significantly across federal states (Figure 3). The highest rates were observed in Saarland (0.2% of all hospital cases in Saarland) and Brandenburg (0.19%), while Bavaria had by far the lowest rate (0.05%, Table 2). Significant regional disparities were observed in hospital-to-hospice transfer rates across Germany, with Risk Ratios (RR) ranging from 1.00 in Bavaria (95% CI 0.92–1.08; reference) to a maximum of 4.36 in Saarland (95% CI 3.92–4.85) and Brandenburg (RR 3.70; 95% CI 3.39–4.05). These findings demonstrate that even after accounting for regional case volumes, the likelihood of a hospice transfer remains highly dependent on geographical location. Linear regression analysis revealed a significant positive correlation between the hospital-to-hospice transfer rate (2023) and regional hospice bed capacity per one million inhabitants (2024). The model demonstrates that bed capacity is a strong predictor of transfer rates (y = 229.6x + 7.9; R² = 0.65; F = 23.96; p = 0.0003). The hospital-to-hospice transfer rate showed no significant correlation with the density of specialized outpatient palliative care (SAPV) teams per one million inhabitants, the proportion of deceased individuals who received SAPV care, nor with the socioeconomic indicators (at-risk-of-poverty rate and Gini index; p > 0.05 for each). This suggests that regional transfer patterns are primarily driven by inpatient infrastructure rather than outpatient availability or socioeconomic disparities. .

Figure 3.

Panel A shows a labeled map of Germany’s federal states in light gray, with Hamburg and Bremen indicated by arrows. Panel B displays the same map colored by the proportion of hospice transfers per state, using a red gradient where Saxony and Saarland are darkest, representing the highest rates, and other regions are lighter, corresponding to lower rates as depicted on the color scale ranging from 0.05 percent to 0.22 percent.

Percentage of hospital cases resulting in patient transfers to hospice. Figure 3 illustrates the percentage of hospital cases resulting in patient transfers to hospice in each federal state of Germany (B). Panel (A) provides a reference map of Germany indicating the federal states.

Table 2.

Hospital to hospice transfer: cases in federal states.

Total number of all hospital cases Total number of hospital to hospice transfers Hospital-to-hospice transfers (%) Hospice bed per 1 million inhabitants Relative risk
(Bavaria as reference)
Lower 95-CI Upper 95-CI
Germany 15,200,893 15,656 0.10% 2.05 1.94 2.18
Federal states
Baden-Württemberg 1,658,292 1,503 0.09% 22.8 1.80 1.67 1.95
Bavaria 2,352,149 1,180 0.05% 17.1 1,00 0.92 1.08
Berlin 690,722 998 0.14% 57.3 2.88 2.65 3.13
Brandenburg 431,509 802 0.19% 56.4 3.70 3.38 4.05
Bremen 166,351 173 0.10% 23.4 2.07 1.77 2.43
Hamburg 386,846 678 0.18% 44.4 3.49 3,18 3.84
Hesse 1,074,931 971 0.09% 35.2 1.80 1,66 1.96
Mecklenburg-Western Pomerania 344,664 430 0.12% 44.2 2.49 2.23 2.78
Lower Saxony 1,340,675 1,771 0.13% 35.5 2.63 2,45 2.83
North Rhine-Westphalia 3,633,091 3,517 0.10% 1.93 1.81 2.06
North Rhine 40.6
Westphalia-Lippe 36.3
Rhineland-Palatinate 732,164 645 0.09% 22.8 1,76 1.6 1.93
Saarland 214,916 470 0.22% 48.4 4,36 3.92 4.85
Saxony 790,355 810 0.10% 27.2 2,04 1.87 2.23
Saxony-Anhalt 440,623 436 0.10% 29.3 1,97 1.78 2.20
Schleswig-Holstein 474,554 640 0.13% 35.9 2,69 2.44 2.96
Thuringia 469,051 632 0.13% 46.5 2,69 2.44 2.96

Of the hospice transfers, 8,399 patients (53.6%) were female, and 7,257 (46.4%) were male. Compared to all adult hospital cases in Germany, the proportion of female patients in the hospice transfer cohort was slightly but significantly higher compared to the total sample (53.6% vs. 52.5%, Chi-square 8.5, df 1, p = .004). In 11,933 of the cases, patients were aged 65 or older (76.2% of all hospice transfers). The proportion of elderly patients was significantly higher in the hospice cohort compared to the cohort of all German hospital cases (Chi-square 3050, df 1, p <.0001; OR: 1,41, 95%-CI: 1,37 - 1,44). Mortality risk was substantially higher in the elderly population with patients aged 65 or older having had nearly 43 times higher odds of a fatal outcome compared to those aged 18–29 (OR 42.86; 95% CI 40.44–45.43; p < 0.001).

According to Federal Health Reporting Service (GBE), in 2023 a total of 47,846 patients received care in inpatient hospices across Germany. Therefore, approximately one-third of hospice admissions involved patients transitioning from a hospital setting.

Diagnoses

Oncological diseases constituted the majority of primary diagnoses in hospital cases involving patient transfers to hospices. A malignant oncological disease was the primary diagnosis in 10,768 cases (68.8% of all discharges to hospice) and appeared as a secondary diagnosis in 20,980 cases. The coding system permits multiple secondary diagnoses but only one primary diagnosis, which explains this distribution. Among the most frequent primary diagnoses, malignant lung tumors accounted for 2,156 cases (13.8% of all hospice discharges), followed by intestinal tumors in 1,087 cases (6.9%), malignant pancreatic tumors in 975 cases (6.2%), and breast cancer in 804 cases (5.1%). Heart failure was the most common non-oncological primary diagnosis, recorded in 336 cases (2.2%). Figure 3 presents an overview of diagnoses in hospital cases leading to hospice transfer.

Metastatic disease was frequently documented as a secondary diagnosis. Liver or bile duct metastases appeared in 19.4% of all hospital cases resulting in hospice transfer, bone metastases in 17.4%, lung metastases in 13%, and brain metastases in 2.6%. Tumour-related anemia occurred in 10%. Infections were also prevalent, with urinary tract infections diagnosed in 17.3% of cases, Covid-19 in 5%, Clostridium difficile-induced enterocolitis in 1.3%, and sepsis in 2.3%. Additionally, delirium was recorded as a secondary diagnosis in 7.1% of cases, hemiparesis in 7%, depressive episodes in 6.9%, and epilepsy or status epilepticus in 6.6%.

Creutzfeldt-Jakob disease had the highest percentage of hospital to hospice transfers, occurring in 10.1% of cases (28 out of 276). Brain malignancies accounted for 3.4% of hospice transfers (625 out of 18,621 cases), while pancreatic malignancies had a transfer rate of 1.6% (975 out of 59,699 cases).

Patients discharged to hospices had a range of significant comorbidities (Table 3, Figure 4, Supplementary Table 1). Among the 15,656 cases, renal failure or chronic kidney disease was coded as secondarydiagnoses in 4315 cases (27.6%), heart failure in 3135 cases (20%), diabetes mellitus in 3203 cases (20,5%) and chronic pulmonary diseases in 1726 cases (11.2%). A detailed list of relevant comorbidities, based on the Charlson Comorbidity Index, is provided in Supplementary Table 1.

Table 3.

Main diagnoses and secondary diagnoses (Comorbidities).

Description ICD-10-GM codes Main diagnoses Secondary diagnoses
Total 15656 100.0% 15656 100.0%
Human immunodeficiency virus disease B20 - 24 9 0.1%
Solid tumors C00 - C76; C80 9647 61.6% 4551 29.1%
Metastases C77 – 79 648 4.1% 15816 101.0%
Lymphomas/Leukemias C81 -97 473 3.0% 251 1.6%
Diabetes mellitus E10 - E13 14 0.1% 3203 20.5%
Dementia F00 - 03; F05.1; G30 - 31 10 0.1% 1119 7.1%
Heart failure I11; I13.00/.20; I50 336 2.1% 3135 20.0%
Myocardial infarction I21 23 0.1% 87 0.6%
Cerebrovascular diseases I61 - 66; G45 - 46 296 1.9% 546 3.5%
Peripheral arterial occlusive disease I70 - I71 25 0.2% 658 4.2%
Chronic pulmonary disease J44; J80 - 84 281 1.8% 1746 11.2%
Ulcer K25 - 26 256 1.6%
Liver cirrhosis/liver failure K70 - 74 140 0.9% 1130 7.2%
Collagenoses M05 - 06; M32 - 35 130 0.8%
Renal failure/Chronic kidney disease N17 - 19 111 0.7% 4315 27.6%

Figure 4.

Infographic depicting top ten main diagnoses leading to hospice care from hospital, including lung cancer, colorectal cancer, pancreatic cancer, and others, alongside ten most common secondary diagnoses such as hypertension, hypokalaemia, and nausea, with corresponding case numbers and percentages.

Common main and secondary diagnoses in hospital cases resulting in patient transfers to hospice.

Discussion

Our analysis reveals the following key findings:

  • 2023, 15,656 adult patients (0.1% of all German hospital cases) were transferred from hospitals to inpatient hospices, representing roughly one-third of all hospice admissions in Germany.

  • Over 75% of transfers involved patients aged 65 or older, with oncological diseases as the primary diagnosis in nearly 70% of cases.

  • Hospital-to-hospice transfer rates correlate with regional hospice bed capacity but show no association with SAPV density, SAPV utilization, or socioeconomic indicators (p>0.05).

The hospital-to-hospice interface in Germany with high regional disparities

This study provides a comprehensive epidemiological profile of the hospital-to-hospice interface in Germany. Nearly 300 inpatient hospices provide end-of-life care (293 hospices listed in the Hospice and Palliative Care Directory as of March 12, 2025) (19). In 2023, just under one-third of the 47,846 inpatient hospice cases were direct hospital transfers. The cohort predominantly comprises elderly patients where 75% are aged 65 or older and those with oncological primary diagnoses represent nearly 70% of the group. While specific data are lacking, the remaining two-thirds of admissions likely occurred via general practice physicians or specialized outpatient palliative care (SAPV) services. Overall, hospital-to-hospice transfers accounted for only 0.12% of all hospital discharges. For context, 439,315 patients (2.9% of adult cases) died in hospitals during the same period. We observed marked regional disparities in hospital to hospice transfers. Patients treated in high-capacity federal states such as Saarland and Brandenburg had more than a fourfold higher likelihood of transfer than patients in Bavaria. These findings align with an analysis of BARMER health insurance data from 2016 to 2019, which reported that 3.3% of deceased individuals received inpatient hospice care (20, 21). That study likewise identified substantial regional variation, with Bremen and Bavaria reporting the lowest utilization rates at 1.6% and 2.0%, respectively, and Berlin and Hamburg reporting the highest at 5.6% and 5.4% (20, 21).

Structural determinism and supply-dependent care

Hospital-to-hospice transfer rates correlate strongly with regional hospice bed capacity. Conversely, SAPV density, its utilization, and socioeconomic indicators show no significant association. This pattern suggests a paradigm of supply-sensitive care where transfers depend primarily on regional hospice capacity rather than outpatient palliative care availability or socioeconomic deprivation. Similar findings emerged from the PallCompare project and the analysis of SAPV provision in Germany. That research demonstrated substantial regional variation in palliative care utilization that could not be explained by patient characteristics or objective medical need according to reference (21, 22). Instead, regional care capacity, provider incentives within differing reimbursement systems, and historically developed care cultures accounted for much of the observed variation as noted in reference (21, 22). Socioeconomic deprivation does not appear to influence access to or provision of inpatient palliative care, even following hospital structural reforms, such as those implemented in Germany’s largest federal state, North Rhine–Westphalia (23).

The “referral gap”: international benchmarks

Comparison with international benchmarks suggests a systemic referral gap in Germany. In the Netherlands and the United States, hospitals serve as the primary referral source for hospice care and account for approximately 52% of admissions (24, 25). In contrast, the German rate of 32.7% indicates structural constraints in discharge management following acute hospital treatment. This comparatively low proportion likely reflects capacity driven care and limited hospice bed availability.

Our findings also diverge from patterns observed in England and the United States, where socioeconomic disadvantage frequently constitutes a major barrier to hospice access (26, 27). In Germany, regional infrastructure appears to outweigh individual socioeconomic status in determining access. These results point to a distinctive structural feature of the German system. Access to hospice care depends less on personal financial resources and more on geographical location and regional service capacity.

Demographic vulnerability: aging and gender as systemic indicators

The data confirm the critical role of hospice care for the geriatric population. Older patients more frequently present with oncological diseases and multiple comorbidities (28, 29). These individuals often endure a high symptom burden across physical, psychological, and social domains at the end of life within various care settings (28–34). Furthermore, older patients consistently prefer palliative care that prioritizes quality of life, symptom relief, and support for caregivers rather than life prolongation or aggressive interventions (35–37). These preferences remain dynamic and change over time as health status, prognosis, and personal values evolve (36, 38). Such shifts underscore the necessity for person-centered advance care planning that adapts to the patient’s journey. Despite these clear preferences, older patients often experience lower quality of care and poorer symptom control than younger cohorts as noted in reference. This discrepancy highlights a significant gap between patient needs and the cur. rent delivery of geriatric end-of-life care (30–34).

Significant gender differences emerged as women transitioned to hospices more frequently despite their lower overall hospital mortality. This disparity likely reflects the collapse of informal support systems. Because women often outlive their partners, they frequently lack the spousal care networks necessary for home-based palliative care. Demographic data confirm that widowed women constitute the majority of elderly care recipients and often live alone (39, 40). This social isolation increases reliance on institutional settings as children or extended social networks provide less stable support than spousal care (40). The structure of the German palliative care system further drives these transitions. Limited outpatient capacity and regional variability often force women to move to hospices or assisted living earlier when informal support proves insufficient (39, 40). As demographic changes increase demand while personnel resources decrease, available regional capacities rather than individual needs often determine the form of care provided. This supply-sensitive logic disproportionately affects elderly women without spousal caregivers (20, 21).

Policy implications and strategic healthcare planning

This study demonstrates that the hospital-to-hospice interface in Germany follows a supply-driven logic where regional capacity outweighs clinical demand. Expert healthcare planning must recognize that expanding outpatient services like SAPV does not automatically substitute for inpatient beds as SAPV density showed no correlation with transfer rates. As German healthcare policy moves toward a closer integration of the inpatient and outpatient sectors, these findings provide crucial insights into the structural barriers that currently hinder a seamless patient journey at the end of life. Consequently, health authorities must critically evaluate whether existing hospice capacities sufficiently meet the actual clinical demand or if current transfer rates merely reflect available space. To ensure equitable access, policymakers must address these structural determinisms by focusing on both infrastructure and the underlying care cultures that influence clinical decision-making.

Our findings align with the theoretical access model of Penchansky and Thomas which identifies five dimensions of healthcare entry: availability, accessibility, acceptability, affordability, and accommodation (23, 41). This analysis specifically highlights accessibility as the primary barrier to hospice care. Future development should prioritize patient-centered networks that integrate digital solutions and telehealth to bridge the gap between acute hospitals and hospices (42–45). Implementing real-time capacity management and digital consultation tools can transition the system from a capacity-based to a needs-based model. By fostering interdisciplinary digital platforms, Germany can ensure that a dignified end-of-life transition remains a universal right rather than a geographic coincidence.

Limitations

This study has several limitations:

  1. The number of hospital cases does not directly correspond to individual patients, as patients may experience multiple hospitalizations within a year, particularly when receiving home care. This means a single patient could theoretically have multiple transfers from a hospital to a hospice. However, hospices typically focus solely on quality-of-life-centered therapy, so transfers from a hospice to a hospital are generally not part of their model of care. Based on our case-based approach, a higher proportion of patients will require transfer to hospice care. Since a hospice transfer usually occurs only once per patient, the proportion of hospital-to-hospice transfers among all hospice admissions is accurately represented in our data.

  2. Hospital mortality was calculated based on hospital cases, but specific causes of death were not specified.

  3. Due to the unavailability of 2023 figures for certain metrics, data from 2022 and 2024 were utilized for specific variables, which potentially limits temporal comparability across all indicators, although significant structural changes in these parameters are unlikely to have occurred within this short timeframe.

  4. We only analyzed data on hospital transfers to hospices, which represent roughly one-third of all hospice admissions. Data on admissions from home and from patients treated with SAPV (specialized palliative home specialized care services) are not available. Therefore, our data only represents a part of inpatient hospice - admissions in Germany.

  5. The findings’ reliability depends on accurate and consistent coding practices in the InEK database. Misclassification or inconsistent coding could introduce biases or inaccuracies. However, reasons for discharge and primary diagnoses must be coded.

  6. Data provided do not cover key aspects of palliative care, such as symptom burden, quality-of-life, and other patient-reported outcome measures (PROMs) and -experienced measures (PREMs) by patients and their families. Thus, the actual assessment of palliative care needs and quality of palliative care is impossible.

  7. The current analysis lacks data regarding the longitudinal patient journey and the continuity of care before hospital admission which prevents a definitive assessment of whether these hospitalizations represent avoidable systemic gaps in the outpatient palliative network.

  8. While this study utilizes the framework of Penchansky and Thomas, the analysis focuses exclusively on the dimension of availability and cannot account for the remaining dimensions of acceptability, affordability, or accommodation (41).

Conclusion

Hospital-to-hospice transfers in Germany remain significantly lower than international averages. This study demonstrates that regional bed density emerges as the most influential factor in these transitions, suggesting a system driven by availability rather than individual clinical necessity. While elderly patients and women constitute the largest groups among these transitions, their frequent transfer to institutional hospice care likely reflects a broader lack of informal spousal support networks within these demographics.

As healthcare policy increasingly seeks to integrate inpatient and outpatient sectors, these findings serve as a critical benchmark for the development of integrated palliative care models. To achieve equitable healthcare, future research must evaluate whether current regional capacities are sufficient and how local care cultures dictate clinical paths. Moving from a capacity-driven infrastructure toward a needs-oriented system is vital to ensure that access to hospice care becomes a standardized right regardless of a patient’s geographic location.

Funding Statement

The author(s) declared that financial support was not received for this work and/or its publication.

Footnotes

Edited by: Abdelbaset Mohamed Elasbali, Jouf University, Saudi Arabia

Reviewed by: Yanjia Zhang, Baptist Health South Florida, United States

Ekaterina Slotina, Friedrich Schiller University Jena, Germany

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.

Author contributions

CS: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. BO: Conceptualization, Methodology, Resources, Writing – review & editing. TS: Conceptualization, Investigation, Methodology, Writing – review & editing. MK: Conceptualization, Formal analysis, Methodology, Writing – review & editing. LR: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Supervision, Validation, Writing – review & editing. MR: Writing – review & editing. ND: Conceptualization, Methodology, Writing – review & editing. MAK: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was used in the creation of this manuscript. AI-based tools (chat GPT) may have been used to improve language and text readability. AI-assisted technology was neither used for the generation, evaluation or interpretation of the data presented in the manuscript, nor for the creation of text, figures or tables.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fonc.2026.1743124/full#supplementary-material

Supplementary Table 1

Extended overview over comorbidities of patients transferred from hospital to hospice care The table shows mortality rates of all coded primary or secondary diagnosis.

Table1.docx (96.8KB, docx)

References

  • 1. Anhang Price R, Tolpadi A, Schlang D, Bradley MA, Parast L, Teno JM, et al. Characteristics of hospices providing high-quality care. J Palliat Med. (2020) 23:1639–43. doi:  10.1089/jpm.2019.0505. PMID: [DOI] [PubMed] [Google Scholar]
  • 2. Breyre AM, Wang DH, Brooten JK, Colwell CB, Hanson KC, Taigman M, et al. Ems care of adult hospice patients- a position statement and resource document of Naemsp and Aahpm. Prehosp Emerg Care. (2023) 27:560–5. doi:  10.1080/10903127.2023.2193978. PMID: [DOI] [PubMed] [Google Scholar]
  • 3. Towns K, Dougherty E, Kevork N, Wiljer D, Seccareccia D, Rodin G, et al. Availability of services in Ontario hospices and hospitals providing inpatient palliative care. J Palliat Med. (2012) 15:527–34. doi:  10.1089/jpm.2011.0453. PMID: [DOI] [PubMed] [Google Scholar]
  • 4. Williams AM, Crooks VA, Whitfield K, Kelley M-L, Richards J-L, DeMiglio L, et al. Tracking the evolution of hospice palliative care in Canada: A comparative case study analysis of seven provinces. BMC Health Serv Res. (2010) 10:147. doi:  10.1186/1472-6963-10-147. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Klinger CA, Howell D, Zakus D, Deber RB. Barriers and facilitators to care for the terminally ill: A cross-country case comparison study of Canada, England, Germany, and the United States. Palliat Med. (2014) 28:111–20. doi:  10.1177/0269216313493342. PMID: [DOI] [PubMed] [Google Scholar]
  • 6. Panarella M, Saarela O, Esensoy AV, Jakda A, Liu ZA. Regional variation in palliative care receipt in Ontario, Canada. J Palliat Med. (2019) 22:1370–7. doi:  10.1089/jpm.2018.0573. PMID: [DOI] [PubMed] [Google Scholar]
  • 7. Finlay IG. Developing a template to plan palliative care services: The Welsh experience. J Pain Symptom Manage. (2009) 38:81–6. doi:  10.1016/j.jpainsymman.2009.04.018. PMID: [DOI] [PubMed] [Google Scholar]
  • 8. Alt-Epping B, Nauck F. Spezialisierte ambulante palliativversorgung (Sapv). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. (2015) 58:430–5. doi:  10.1007/s00103-015-2125-6. PMID: [DOI] [PubMed] [Google Scholar]
  • 9. Melching H. Neue gesetzliche regelungen für die palliativversorgung und ihre implikationen für politik und praxis. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. (2017) 60:4–10. doi:  10.1007/s00103-016-2480-y. PMID: [DOI] [PubMed] [Google Scholar]
  • 10. Kamp MA, Willert A-C, Dunkl V, Kowski AB, Golla H. Palliative begleitung bei neuroonkologischen erkrankungen: Schwerkranke menschen in multidisziplinären teams behandeln. DNP–Die Neurol Psychiatr. (2025) 26:35–42. doi:  10.1007/s15202-025-6389-x. PMID: 41770356 [DOI] [Google Scholar]
  • 11. GKV-SpitzenverbandArbeiterwohlfahrt Bundesverband e. V.Bundesverband Kinderhospiz e. V.Deutscher Caritasverband e. V.Deutscher Hospiz- und PalliativVerband e. V.Deutscher Kinderhospizverein e. V . Rahmenvereinbarung nach § 39a Abs. 1 Satz 4 Sgb V über Art und Umfang sowie Sicherstellung der stationären Hospizversorgung in der Fassung vom 18.11.2024. In: GKV-Spitzenverband (2024). Berlin: GKV Spitzenverband. Available online at: https://www.gkv-spitzenverband.de/media/dokumente/krankenversicherung_1/hospiz_palliativversorgung/2024-11-18_Rahmenvereinbarung_39a_Abs1_Satz_4:SGB_V_stat_Hospizversorgung_Erw.pdf. (Accessed March 12, 2026). [Google Scholar]
  • 12. Izumi S, Noble BN, Candrian CB, Tjia J, Bordley J, Mensik J, et al. Health care worker perceptions of gaps and opportunities to improve hospital-to-hospice transitions. J Palliat Med. (2020) 23:900–6. doi:  10.1089/jpm.2019.0513. PMID: [DOI] [PubMed] [Google Scholar]
  • 13. Peuten S, Jaspers B, Hainsch-Muller I, Aulmann C, Schneider W, Radbruch L, et al. Concept-dependent and -independent care effects of site-specific care concepts using "Pain" as an example. Schmerz. (2024) 38:433–40. doi:  10.1007/s00482-023-00754-1. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Kasdorf A, Dust G, Vennedey V, Rietz C, Polidori MC, Voltz R, et al. What are the risk factors for avoidable transitions in the last year of life? A qualitative exploration of professionals' perspectives for improving care in Germany. BMC Health Serv Res. (2021) 21:147. doi:  10.1186/s12913-021-06138-4. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Wang SY, Aldridge MD, Gross CP, Canavan M, Cherlin E, Johnson-Hurzeler R, et al. Transitions between healthcare settings of hospice enrollees at the end of life. J Am Geriatr Soc. (2016) 64:314–22. doi:  10.1111/jgs.13939. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Bundesinstitut für Arzneimittel und Medizinprodukte . Internationale statistische klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10. Revision, German Modification, Version 2024. In: Bundesinstitut für Arzneimittel und Medizinprodukte (2025). Berlin: Bundesinstitut für Arzneimittel und Medizinprodukte. Available online at: https://klassifikationen.bfarm.de/icd-10-gm/kode-suche/htmlgm2024/index.htm. (Accessed March 12, 2026). [Google Scholar]
  • 17. Bundesinstitut für Arzneimittel und Medizinprodukte . Operationen- und prozedurenschlüssel, Version 2024 (2025). Available online at: https://klassifikationen.bfarm.de/ops/kode-suche/htmlops2024/index.htm. (Accessed March 12, 2026).
  • 18. Altman DG. Practical Statistics for Medical Research. New York: Taylor & Francis; (1990). [Google Scholar]
  • 19. Deutsche Gesellschaft für Palliativmedizin . Wegweiser Hospiz- und Palliativversorgung in Deutschland (2025). Available online at: https://wegweiser-hospiz-palliativmedizin.de. (Accessed March 12, 2026)
  • 20. Ditscheid B, Krause M, Lehmann T, Stichling K, Jansky M, Nauck F, et al. Palliative care at the end of life in Germany: Utilization and regional distribution. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. (2020) 63:1502–10. doi:  10.1007/s00103-020-03240-6. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Ditscheid B, Meissner F, Gebel C, Hennig B, Marschall U, Meissner W, et al. Utilization of palliative care at the end of life in Germany: Temporal trend (2016-2019) and regional variability. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. (2023) 66:432–42. doi:  10.1007/s00103-023-03683-7. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Freytag A, Meissner F, Krause M, Lehmann T, Jansky MK, Marschall U, et al. A regional comparison of outcomes quality and costs of general and specialized palliative care in Germany: A claims data analysis. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. (2023) 66:1135–45. doi:  10.1007/s00103-023-03746-9. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Von Sass C, Wedding U, Bergmann J, Fink L, Adelstein J, Van Oorschot B, et al. Impact of the hospital structural reform and socio-economic deprivation in North Rhine-Westphalia (Nrw) on the accessibility of specialized inpatient palliative care. Gesundheitswesen. (2025). doi:  10.1055/a-2633-5943. PMID: [DOI] [PubMed] [Google Scholar]
  • 24. West E, Pasman HR, Galesloot C, Lokker ME, Onwuteaka-Philipsen B, Euro I. Hospice care in the Netherlands: Who applies and who is admitted to inpatient care? BMC Health Serv Res. (2016) 16:33. doi:  10.1186/s12913-016-1273-1. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Furuno JP, Noble BN, McPherson ML, Lapane KL, Sera L, Izumi S, et al. Variation in hospice patient and admission characteristics by referral location. Med Care. (2020) 58:1069–74. doi:  10.1097/mlr.0000000000001415. PMID: [DOI] [PubMed] [Google Scholar]
  • 26. Sleeman KE, De Brito M, Etkind S, Nkhoma K, Guo P, Higginson IJ, et al. The escalating global burden of serious health-related suffering: Projections to 2060 by world regions, age groups, and health conditions. Lancet Glob Health. (2019) 7:e883–92. doi:  10.1016/S2214-109X(19)30172-X. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Barclay JS, Kuchibhatla M, Tulsky JA, Johnson KS. Association of hospice patients' income and care level with place of death. JAMA Intern Med. (2013) 173:450–6. doi:  10.1001/jamainternmed.2013.2773. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Grudzen CR, Richardson LD, Morrison M, Cho E, Morrison RS. Palliative care needs of seriously ill, older adults presenting to the emergency department. Acad Emerg Med. (2010) 17:1253–7. doi:  10.1111/j.1553-2712.2010.00907.x. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Ryan T, Ingleton C, Gardiner C, Parker C, Gott M, Noble B. Symptom burden, palliative care need and predictors of physical and psychological discomfort in two UK hospitals. BMC Palliat Care. (2013) 12:11. doi:  10.1186/1472-684X-12-11. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Lindskog M, Tavelin B, Lundstrom S. Old age as risk indicator for poor end-of-life care quality - a population-based study of cancer deaths from the Swedish Register of Palliative Care. Eur J Cancer. (2015) 51:1331–9. doi:  10.1016/j.ejca.2015.04.001. PMID: [DOI] [PubMed] [Google Scholar]
  • 31. Lindemann K, Martinsson L, Kaasa S, Lindquist D. Elderly gynaecological cancer patients at risk for poor end of life care: A population-based study from the Swedish Register of Palliative Care. Acta Oncol. (2020) 59:636–43. doi:  10.1080/0284186X.2020.1744717. PMID: [DOI] [PubMed] [Google Scholar]
  • 32. Quinn KL, Shurrab M, Gitau K, Kavalieratos D, Isenberg SR, Stall NM, et al. Association of receipt of palliative care interventions with health care use, quality of life, and symptom burden among adults with chronic noncancer illness: A systematic review and meta-analysis. JAMA. (2020) 324:1439–50. doi:  10.1001/jama.2020.14205. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Grudzen CR, Siman N, Cuthel AM, Adeyemi O, Yamarik RL, Goldfeld KS, et al. Palliative care initiated in the emergency department: A cluster randomized clinical trial. JAMA. (2025) 333:599–608. doi:  10.1001/jama.2024.23696. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Morita T, Kuriya M, Miyashita M, Sato K, Eguchi K, Akechi T. Symptom burden and achievement of good death of elderly cancer patients. J Palliat Med. (2014) 17:887–93. doi:  10.1089/jpm.2013.0625. PMID: [DOI] [PubMed] [Google Scholar]
  • 35. Waller A, Sanson-Fisher R, Nair BR, Evans T. Preferences for end-of-life care and decision making among older and seriously ill inpatients: A cross-sectional study. J Pain Symptom Manage. (2020) 59:187–96. doi:  10.1016/j.jpainsymman.2019.09.003. PMID: [DOI] [PubMed] [Google Scholar]
  • 36. Gonzalez-Gonzalez AI, Schmucker C, Nothacker J, Nury E, Dinh TS, Brueckle MS, et al. End-of-life care preferences of older patients with multimorbidity: A mixed methods systematic review. J Clin Med. (2020) 10. doi:  10.3390/jcm10010091. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Johnston BM, Daveson B, Normand C, Ryan K, Smith M, McQuillan R, et al. Preferences of older people with a life-limiting illness: A discrete choice experiment. J Pain Symptom Manage. (2022) 64:137–45. doi:  10.1016/j.jpainsymman.2022.04.180. PMID: [DOI] [PubMed] [Google Scholar]
  • 38. Robinson L, Dewhurst F, Huggin A, Stow D, Stenson C, Westhead E, et al. Exploring older people's end-of-life care preferences over time: A scoping review. Palliat Med. (2025) 39:665–77. doi:  10.1177/02692163251331161. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Dasch B, Lenz P. Der sterbeort von tumorpatienten im zeitlichen trend. Der Onkologe. (2021) 27:602–9. doi:  10.1007/s00761-021-00926-7. PMID: 41770356 [DOI] [Google Scholar]
  • 40. Dorin L, Krupa E, Metzing S, Buscher A. Gender disparities in German home-care arrangements. Scand J Car Sci. (2016) 30:164–74. doi:  10.1111/scs.12236. PMID: [DOI] [PubMed] [Google Scholar]
  • 41. Penchansky R, Thomas JW. The concept of access: Definition and relationship to consumer satisfaction. Med Care. (1981) 19:127–40. doi:  10.1097/00005650-198102000-00001. PMID: [DOI] [PubMed] [Google Scholar]
  • 42. Greer JA, Jacobs J, Pensak N, MacDonald JJ, Fuh CX, Perez GK, et al. Randomized trial of a tailored cognitive-behavioral therapy mobile application for anxiety in patients with incurable cancer. Oncologist. (2019) 24:1111–20. doi:  10.1634/theoncologist.2018-0536. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Greer JA, Jacobs JM, Pensak N, Nisotel LE, Fishbein JN, MacDonald JJ, et al. Randomized trial of a smartphone mobile app to improve symptoms and adherence to oral therapy for cancer. J Natl Compr Canc Netw. (2020) 18:133–41. [DOI] [PubMed] [Google Scholar]
  • 44. Greer JA, Temel JS, El-Jawahri A, Rinaldi S, Kamdar M, Park ER, et al. Telehealth vs in-person early palliative care for patients with advanced lung cancer: A multisite randomized clinical trial. JAMA. (2024) 332:1153–64. doi:  10.1001/jama.2024.13964. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. May S, Gehlhaar A, Stahlhut K, Kamp MA, Heinze M, Allsop M, et al. Let's put it this way: You can't really live without it - Digital technologies in routine palliative care delivery: An explorative qualitative study with patients and their family caregivers in Germany. BMC Health Serv Res. (2024) 24:702. doi:  10.1186/s12913-024-11150-5. PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Table 1

Extended overview over comorbidities of patients transferred from hospital to hospice care The table shows mortality rates of all coded primary or secondary diagnosis.

Table1.docx (96.8KB, docx)

Data Availability Statement

The study complied with the ethical standards set in the 1964 Declaration of Helsinki and its subsequent revisions. Approval for the study protocol was granted by the institutional and local ethics committee at Friedrich Schiller University Jena (Study ID: 2025-3696-BO-D) and Brandenburg Medical School, Germany (Study ID: 190032024-ANF). The findings align with the STROBE guidelines for observational studies [16].

The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES